Skip to content

Orexin Gene in Anorexia Nervosa

The Methylation Level of the Orexin Gene in Anorexia Nervosa: Relationship With Eating Disorder, Depressive State, and Sleep Quality

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06800898
Acronym
ORESSANNE
Enrollment
60
Registered
2025-01-30
Start date
2024-06-19
Completion date
2026-06-30
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa

Keywords

Orexins, Methylation, Epigenetics, Psychiatric comorbidities, Eating disorder, Quality of sleep

Brief summary

The objectives of this study will be to determine the methylation of the promoter of the Orexin A (OX-A) and B (OX-B) genes in young women (\> 18 years) with Anorexia Nervosa (AN), compared with a control group; and to evaluate the relationship of promoter methylation of the genes for OX-A and OX-B with the severity of the eating disorder, psychiatric comorbidities (in particular, depression), and sleep quality.

Interventions

OTHERBlood samples and Questionnaires

Blood samples for methylation of the promoter of the OX-A and OX-B genes and questionnaires: Eating Disorder Examination Q Eating Disorder Inventory 3 Major Depression Inventory Symptom Checklist-revised ESS - Epworth Sleepiness Scale Pittsburgh Sleep Quality Index Horne \& Ostberg questionnaire

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients with Anorexia Nervosa: Inclusion Criteria: * Female sex * Age 18 years and older * Anorexia Nervosa * Hospitalized at the Division of Eating and Nutrition Disorders, Istituto Auxologico Italiano, IRCCS, Piancavallo, Italy

Exclusion criteria

* Absence of signed informed consent Control group: Inclusion Criteria: * Female sex * Age 18 years and older * Body Mass Index between 18.5 and 24.9 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Orexin A promoter methylationBaselinePercentage of Orexin A promoter methylation
Orexin B promoter methylationBaselinePercentage of Orexin B promoter methylation

Countries

Italy

Contacts

CONTACTAlessandro Sartorio, MD
sartorio@auxologico.it+390261911
CONTACTLuca Grappiolo, Dr.
luca.grappiolo@auxologico.it+390261911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026